Using survival analysis, high TSPAN4 expression contributed to a worse prognosis in OS of GBMLGG subgroup patients, such as patients with Glioblastoma, Oligodendroglioma, Astrocytoma, WHO grade: G3, or WHO grade: G4. Here, TSPAN4 is linked to oligodendroglioma.